Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 11, 2004
Pneumonia caused by Mycobacterium kansasii in a series of patients without recognised immune defectS M Arend, E Cerdá de Palou, P de Haas, et al.
Inhalation Toxicology|June 24, 1999
Pathological and immunological effects of respirable coal fly ash in male Wistar ratsJ A Dormans, P A Steerenberg, J H Arts, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2016
Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of TuberculosisN Alsaad, J A Dijkstra, O W Akkerman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 23, 2003
Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?H T W Quy, N T N Lan, M W Borgdorff, et al.
Molecular Microbiology|July 1, 1992
Mycobacteria contain two groEL genes: the second Mycobacterium leprae groEL gene is arranged in an operon with groEST F Rinke de Wit, S Bekelie, A Osland, et al.
The European Respiratory Journal|February 12, 2011
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experienceA D Pranger, R van Altena, R E Aarnoutse, et al.
International Journal of Immunopathology and Pharmacology|October 14, 2009
Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in miceJ E M De Steenwinkel, G J De Knegt, M T Ten Kate, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 10, 2006
Molecular epidemiology of Mycobacterium tuberculosis in China: a nationwide random survey in 2000W M Li, S M Wang, C Y Li, et al.
Antimicrobial Agents and Chemotherapy|January 11, 2017
Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant TuberculosisR van Altena, J A Dijkstra, M E van der Meer, et al.
Pageof 19